Admission Serum 25-Hydroxyvitamin D and Survival in Older Hospitalized Adults with Delirium: A Retrospective Cohort Study
Diagnostics · 18.11.2026 · 16 (22) · 3853
DOI: 10.3390/diagnostics16223853 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diagnostics, online erschienen am 18.11.2026. Verfasst von Dana Kagansky und 9 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Delir
Abstract (Originalsprache)
Background
The prognostic significance of serum 25-hydroxyvitamin D [25(OH)D] among older inpatients with established delirium remains uncertain.
Methods
This retrospective single-center cohort included 184 adults aged ≥65 years with delirium and serum 25(OH)D measured within seven days of admission during the period of 2020–2025. Outcomes were all-cause mortality and hospital length of stay. Vitamin D was modeled continuously in Cox regression; baseline comparisons were exploratory.
Results
During follow-up, 47 patients (25.5%) died: 31/120 (25.8%) with 25(OH)D concentrations < 30 ng/mL and 16/64 (25.0%) with concentrations ≥30 ng/mL (log-rank p = 0.731). Median follow-up was 30.4 months (reverse Kaplan–Meier; 95% CI 28.1–34.0). The proportional-hazards-corrected multivariable Cox estimate per 10-ng/mL increase was HR 1.09 (95% CI 0.91–1.30; p = 0.354); the minimally adjusted age–sex–CCI estimate was HR 1.07 (95% CI 0.91–1.26; p = 0.407). Adjusted median length of stay was also not associated with serum 25(OH)D (difference of −0.81 days per 10-ng/mL increase, 95% CI −2.18 to 0.56; p = 0.250). Results were consistent across ward, landmark, spline, ridge-penalized, and additional sensitivity analyses. Other covariate and baseline associations were exploratory.
Conclusions
Serum 25(OH)D was not significantly associated with mortality or length of stay in this selected retrospective single-center cohort of hospitalized older adults with documented delirium and timely 25(OH)D measurement. The findings were consistent across multiple sensitivity analyses, although the confidence intervals do not establish equivalence or exclude smaller associations. This study cannot evaluate delirium incidence or the effects of vitamin D supplementation. Substantial cohort exclusions, the moderate sample size, limited mortality events, and unavailable functional and frailty measures restrict generalizability. The null findings are informative within this selected population but should not be generalized beyond it without prospective multicenter validation.
Zitieren
APA
Kagansky, D., Laufer, H. V., Wurman, M., Nattel-Wright, D., Pinco, E., Bitan, M., Trotzky, D., Sharfman, M., Levy, Y., & Kagansky, N. (2026). Admission Serum 25-Hydroxyvitamin D and Survival in Older Hospitalized Adults with Delirium: A Retrospective Cohort Study. Diagnostics, 16(22), 3853. https://doi.org/10.3390/diagnostics16223853
Vancouver
Kagansky D, Laufer HV, Wurman M, Nattel-Wright D, Pinco E, Bitan M, et al. Admission Serum 25-Hydroxyvitamin D and Survival in Older Hospitalized Adults with Delirium: A Retrospective Cohort Study. Diagnostics. 2026;16(22):3853. doi:10.3390/diagnostics16223853
BibTeX
@article{Kagansky2026,
author = {Kagansky, Dana and Laufer, Hadar Vaknin and Wurman, Maya and Nattel-Wright, Dror and Pinco, Erica and Bitan, Michal and Trotzky, Daniel and Sharfman, Miya and Levy, Yochai and Kagansky, Nadya},
title = {Admission Serum 25-Hydroxyvitamin D and Survival in Older Hospitalized Adults with Delirium: A Retrospective Cohort Study},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {22},
pages = {3853},
doi = {10.3390/diagnostics16223853}
}
EUVIMED